Skip to content

Monday, October 26, 2026

Top Stories Global Economy Markets Topics & Series Contributors Opinion

All desks ⌄

Economy & Finance

Economy Investing Central Banks Digital Currency Fintech Research & Analysis Technicals

Power & Business

Politics Business Law Insights & Views Governance Market Roundups

Science & Society

Technology Science Nature Health Life

In focus · trending topic

CLDN18.2

1 stories · following the connections

Oncology researchers review poster displays during the ESMO Congress at IFEMA Madrid. / EconoTimes.ai

AstraZeneca Drug Doubles Survival in Later-Line CLDN18.2 Cancer Trial

By Naomi CalderOct 26, 2026, 12:32 PM UTC

←1→Page 1 of 1

Connected markets

Follow the indicators behind the story.

Illustrative data · 06 Oct 2026, 08:00 UTC

Keep exploring

France Hyperliquid Perpetual contracts Emmanuel Macron French protests Trade unions EWZ Brazilian equities

Coverage

Global Economy Markets Technology Politics All news

Intelligence

Topics & Series Contributors Research

Company

About us Become a contributor Contact info@econotimes.com Editorial standards

© 2026 PUBLISH Holdings LLC.Privacy Terms of use Our standards

Home Markets Topics Search